cp 96345 has been researched along with Hypertension in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cezaretti, ML; Gavras, H; Gavras, I; Ginoza, M; Kohlmann, O; Leeman, SE; Ramos, OL; Ribeiro, AB; Tavares, A; Zanella, MT | 1 |
| Cesaretti, ML; Gavras, H; Gavras, I; Ginoza, M; Kohlmann, O; Leeman, SE; Ramos, OL; Ribeiro, AB; Tavares, A; Zanella, MT | 1 |
2 other study(ies) available for cp 96345 and Hypertension
| Article | Year |
|---|---|
Cardiovascular effects of a specific nonpeptide antagonist of substance P (NK-1) receptor in DOCA-salt hypertension.
Topics: Animals; Biphenyl Compounds; Blood Pressure; Cardiac Output; Cardiac Volume; Desoxycorticosterone; Heart Rate; Hemodynamics; Hypertension; Hypnotics and Sedatives; Male; Neurokinin-1 Receptor Antagonists; Rats; Rats, Wistar; Sodium Chloride; Substance P; Vascular Resistance | 1995 |
Role of substance P in blood pressure regulation in salt-dependent experimental hypertension.
Topics: Animals; Biphenyl Compounds; Blood Pressure; Desoxycorticosterone; Hypertension; Male; Neurokinin-1 Receptor Antagonists; Rats; Rats, Inbred WKY; Substance P; Vasodilator Agents | 1997 |